⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Sirtuin-1 (SIRT1) and Sirtuins
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-13 — Interfering in the USP25-SIRT1 Interaction Reduces the Onset of Cellular Senescence: [mechanism-plausible] News report, with primary experimental details unavailable in the supplied summary, nominates the USP25–SIRT1 interaction as a target for reducing senescence entry, without resolving the relevant changes in SIRT1 regulation or establishing equivalence to general SIRT1 activation, organismal aging benefits, or human therapeutic efficacy. [mechanism-plausible] (novelty: 3)
- 2026-11-12 — Chronobiology of Aging: Interactions Between Circadian Rhythms, Oxidative Stress, and Inflammation.: [expert-opinion] Chronobiology review provides a systems-level context for sirtuin–circadian interactions in aging, but the supplied finding does not specify SIRT1-dependent causal experiments or establish sirtuin-mediated human benefits from chronotherapy. [expert-opinion] (novelty: 3)
- 2026-10-15 — Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.: Mouse cardiac-aging study [animal-model] implicates an AMPKα2/sirtuin axis in exosome-associated remodeling of lysine β-hydroxybutyrylation and improved cardiac function, but the supplied evidence does not resolve the responsible sirtuin isoform or establish direct enzymatic control of these modifications or human efficacy. [animal-model] (novelty: 3)
- 2026-07-23 — Galangin attenuates UVB-induced skin photoaging through SIRT1-dependent LC3 deacetylation and autophagy modulation.: 2026 HDF + mouse UVB skin photoaging study: galangin (flavonoid) engages SIRT1 to directly deacetylate LC3, driving autophagic flux and attenuating senescence/MMP/collagen-loss readouts — adds a concrete SIRT1-substrate (LC3) axis distinct from canonical transcription-factor deacetylation, extending the sirtuin repertoire into direct ATG-protein PTM control in dermal fibroblasts. [animal-model] (novelty: 3)
- 2026-10-02 — Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults: Confirmatory NR RCT in adults with elevated SBP indirectly tests the NAD-precursor → sirtuin-cofactor arm as a route to vascular benefit; pilot showed ~8 mmHg SBP drop but no direct sirtuin activity readout — mechanistic attribution to SIRT1 remains inferential. [human-rct] (novelty: 3)
- 2026-07-25 — SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.: 2026 preclinical study extends the mitochondrial-sirtuin SIRT3 repertoire beyond tendon redox homeostasis to the vascular endothelium: SIRT3 loss drives mitochondrial dysfunction and EndMT in aged and Sirt3-KO mice plus senescent HUVECs, nominating SIRT3 as a candidate target for vascular aging. [animal-model] (novelty: 3)
- 2026-06-16 — Resveratrol suppresses GATA4/Sortilin pathway to attenuate vascular smooth muscle cell senescence-associated secretory phenotype and vascular aging-related atherosclerosis.: cross-connection with vascular-aging: Adds a SIRT1-ligand (resveratrol) mechanistic route into vascular smooth muscle senescence and atherosclerosis via GATA4/Sortilin suppression, connecting the sirtuin-activator narrative to a specific vascular-wall SASP axis. (novelty: 3)
- 2026-04-02 — Ceramic-based biomaterials: Combining regeneration with anti-senescence.: 2026 preclinical ZnCS bioceramic study: Zn²⁺ and silicate ions from hardystonite scaffolds engage a PI3K–AKT–SIRT1 axis in BMSCs to suppress senescence and accelerate osteoporotic bone regeneration, extending SIRT1 upstream activators to inorganic ion inputs from biomaterials — preclinical only, no direct enzymatic sirtuin assay beyond pathway readouts. [animal-model] (novelty: 4)
- 2026-09-20 — NAD-sirtuin-mitochondrial quality control in lens epithelial cells: a candidate modulatory network in crystalline lens aging.: 2026 evidence-stratified review nominates a lens-epithelial NAD–sirtuin axis coupled to mitochondrial quality control as a candidate modulator of crystalline lens aging, extending the sirtuin repertoire to LECs while explicitly noting that age-dependent NAD change in normal human LECs and a causal epithelial-to-tissue pathway remain unproven — synthesis only, no direct sirtuin activity assays in human lens. [expert-opinion] (novelty: 3)
- 2026-09-23 — A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.: 2026 aging-mouse study frames CL256B-derived hesperetin as engaging a CISD2/SIRT1 axis to drive metabolic and functional benefits, adding a microbiome-generated flavonoid metabolite to the SIRT1-activator roster — mechanistic invocation alongside CISD2, no direct SIRT1 enzymatic assay. [animal-model] (novelty: 3)
- 2026-09-18 — Imeglimin provides dual hepatic and skeletal muscle protection in experimental MASH-associated sarcopenia.: cross-connection with mtor-nutrient-sensing: Imeglimin coordinately engaged AKT–mTOR anabolic signaling and NAD+/NAMPT (a SIRT1 substrate supply arm) in aged/MASH muscle, linking the mTOR anabolic arm to NAD-sirtuin biology within a single drug’s mechanism. (novelty: 3)
- 2026-06-05 — Endurance exercise improves age- and obesity-related cardiac dysfunction and locomotor impairment through muscle Gγ1 gene in Drosophila.: Drosophila study places Sir2 (fly SIRT1 ortholog) downstream of muscle Gγ1 in mediating endurance-exercise benefits on age- and obesity-related cardiac and locomotor decline via a Sir2/PGC-1α mitochondrial axis — fly-level evidence of a new upstream input into sirtuin-PGC-1α signaling. [animal-model] (novelty: 3)
- 2026-09-14 — GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.: 2026 GLP-1 RA geroprotection review invokes AMPK–SIRT1 activation as one of the mechanistic substrates plausibly linking GLP-1R signaling to healthspan effects beyond glycemia — narrative synthesis, no direct sirtuin activity data. [expert-opinion] (novelty: 3)
- 2026-09-09 — SIRT3-dependent mitochondrial redox homeostasis protects against age-related tendon degeneration.: 2026 murine supraspinatus tendon study extends the sirtuin family’s tissue repertoire: age-related SIRT3 decline disrupts mitochondrial redox homeostasis in tenocytes, and SIRT3 restoration reverses oxidative tenocyte senescence via SOD2 and Keap1/Nrf2/HO-1 — adds SIRT3 as a mitochondrial-sirtuin node in tendon aging distinct from SIRT1’s canonical roles. [animal-model] (novelty: 3) [animal-model] (novelty: 3)
- 2026-09-10 — Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling.: 2026 ApoE mouse + cardiomyocyte study: mitochondria-targeted esculetin engages an AMPK–SIRT1 axis (with parallel p38 MAPK suppression) to attenuate age- and hypercholesterolemia-driven cardiac remodeling, extending the SIRT1-activator roster to a mitochondria-targeted natural-product coumarin with metformin-comparable effects — preclinical only. [animal-model] (novelty: 3)
- 2026-08-24 — Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes.: 2026 MDS-BMMSC in vitro study invokes an NAD/SIRT1 arm (alongside AMPK and EZH2) in Qinghuang powder’s rescue of stromal senescence and energy metabolism, extending the SIRT1-adjacent modulator list to a TCM formulation acting on patient-derived marrow stromal cells — mechanistic framing, no direct SIRT1 activity assay reported. [mechanism-plausible] (novelty: 3)
- 2026-08-30 — SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin‐Modifying Complexes: 2026 preclinical mechanistic study: SIRT1 stabilizes heterochromatin-modifying complexes to silence LINE-1 retrotransposons, extending SIRT1’s role beyond deacetylation of transcription factors into direct maintenance of repeat-element heterochromatin and genomic stability. [mechanism-plausible] (novelty: 3)
- 2026-06-26 — Meta-analysis of DNA methylation aging signatures in 17 human tissues.: 2026 multi-tissue human methylation meta-analysis (>15,000 profiles, 17 tissues) identifies an NAD-metabolism-linked gene cluster among the age-associated, potentially modifiable methylation signatures, offering an indirect population-scale link between methylation aging and the NAD-dependent sirtuin cofactor pool. [human-observational] (novelty: 3)
- 2026-07-15 — Resveratrol exerts anti-aging effects in young but pro-aging effects in middle-aged C. elegans via a gerosuppressive daf-16/dod-6/sod-3 axis.: cross-connection with foxo-transcription-factors: Resveratrol — canonically framed as a SIRT1 activator — is shown here to produce age-dependent opposite longevity outcomes via a daf-16/dod-6/sod-3 (worm FOXO) axis, complicating the sirtuin-activator narrative with a FOXO-level readout that flips sign with treatment age. (novelty: 3)
- 2026-08-10 — Fibrillarin Resists Cellular Senescence Via SIRT1-Dependent Nicotinamide Metabolism and Its Inhibition Sensitizes Senolytic Therapy in Esophageal Squamous Cell Carcinoma.: 2026 ESCC preclinical study: nucleolar fibrillarin (FBL) stabilizes SIRT1 protein and sustains nicotinamide metabolism to suppress senescence, adding a post-translational stabilizer upstream of SIRT1 and linking SIRT1’s anti-senescence role to nicotinamide/NAD-adjacent metabolism in cancer cells. [mechanism-plausible] (novelty: 3)
- 2026-08-05 — Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.: 2026 hepatocyte-specific Sirt6-KO mouse study extends the sirtuin family’s aging repertoire to a female-specific hepatic estrogen-control axis: liver SIRT6 loss induces SULT1E1-mediated estrogen depletion and cuts female median lifespan ~17.6%, with MDL-800 activator rescue — adds a sex-dimorphic endocrine node distinct from SIRT1’s canonical roles. [animal-model] (novelty: 3)
- 2026-06-19 — Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.: 2026 centenarian-genetics-to-mechanism study: Ashkenazi centenarian-enriched SIRT6 missense variants, knocked into hESC-derived lineages, raise endogenous SIRT6 protein and rebalance its enzymatic activities, with AAV-SIRT6 and fucoidan-FV partially recapitulating the effect in progeria fibroblasts — extends the sirtuin family beyond SIRT1/SIRT5 with a rare direct human-longevity-genetics bridge, still preclinical. [mechanism-plausible] (novelty: 4)
- 2026-07-15 — The SIRT5-SUCLG2 desuccinylation axis delays ovarian aging via a mitochondrial-epigenetic regulatory mechanism.: 2026 ovarian aging study extends the sirtuin family beyond SIRT1: SIRT5-mediated desuccinylation of mitochondrial SUCLG2 gates TCA-cycle-derived acetyl-CoA and downstream histone acetylation, and a desuccinylation-mimetic SUCLG2 gene therapy delays ovarian aging — adds SIRT5 as a mito-epigenetic node distinct from SIRT1’s canonical deacetylase roles. [animal-model] (novelty: 3)
- 2026-07-23 — Exercise attenuates atherosclerosis by inhibiting eWAT aging via targeting SIRT1/pyruvate carboxylase pathway.: 2026 HFD mouse study: exercise-induced SIRT1 activation in epididymal WAT suppresses pyruvate carboxylase, and PC knockdown partially recapitulates exercise’s anti-senescence/anti-atherosclerosis effect — nominates a SIRT1→PC axis linking sirtuin signaling to adipose-tissue-driven vascular aging. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Interfering in the USP25-SIRT1 Interaction Reduces the Onset of Cellular Senescence
13-nov-2026
novelty 3
per-area 3
strengthens
Chronobiology of Aging: Interactions Between Circadian Rhythms, Oxidative Stress, and Inflammation.
12-nov-2026
novelty 3
per-area 3
strengthens
Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study.
19-oct-2026
novelty 2
per-area 1
mentions
Caffeine and Exercise in Obesity-Associated Brain Aging and Neurodegeneration: Mechanistic Insights into AMPK/SIRT1/PGC-1α, BDNF/TrkB, and NLRP3 Inflammasome Signaling.
16-oct-2026
novelty 2
per-area 2
strengthens
Proteomic and β-hydroxybutyrylation Landscapes Reveal AMPKα2-Associated Modulation in HUCMSC-Derived Exosome-Mediated Amelioration of Cardiac Aging.
15-oct-2026
novelty 3
per-area 3
strengthens
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
02-oct-2026
novelty 3
per-area 3
strengthens
Mitochondria and associated complexes as therapeutic targets in aging: From biomacromolecular structure-function insights to clinical translation.
01-oct-2026
novelty 2
per-area 2
mentions
Mitochondrial-Targeted Phytochemicals in Reproductive Aging: Mechanisms and Translational Potential.
25-sep-2026
novelty 2
per-area 2
strengthens
Sirtuin signaling as therapeutic targets of immunosenescence.
25-sep-2026
novelty 2
per-area 2
strengthens
Autophagy in sarcopenic obesity: muscle-adipose crosstalk, metabolic regulation, and exercise-based interventions.
24-sep-2026
novelty 2
per-area 2
mentions
A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.
23-sep-2026
novelty 3
per-area 3
strengthens
NAD-sirtuin-mitochondrial quality control in lens epithelial cells: a candidate modulatory network in crystalline lens aging.
20-sep-2026
novelty 3
per-area 3
strengthens
The dimorphic brain in ischemic stroke: How sex and age shape molecular pathophysiology and therapeutic responsiveness.
16-sep-2026
novelty 2
per-area 2
strengthens
GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.
14-sep-2026
novelty 3
per-area 3
strengthens
Resveratrol engages SIRT1/AMPK networks to restore BDNF signaling, autophagy, and mitochondrial function in age-related cognitive decline: A geroscience perspective.
12-sep-2026
novelty 2
per-area 2
strengthens
Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling.
10-sep-2026
novelty 3
per-area 3
strengthens
Subcellular sirtuin signaling networks: pivotal regulators of cardiovascular homeostasis and remodeling.
10-sep-2026
novelty 2
per-area 3
strengthens
SIRT3-dependent mitochondrial redox homeostasis protects against age-related tendon degeneration.
09-sep-2026
novelty 3
per-area 3
strengthens
A Mechanistic Explanation for SIRT1’s Effects
31-aug-2026
novelty 2
per-area 2
strengthens
SIRT1 Silences L1 Retrotransposons by Stabilizing Heterochromatin‐Modifying Complexes
30-aug-2026
novelty 3
per-area 3
strengthens
Qinghuang powder ameliorates cellular senescence and energy metabolism abnormalities in bone marrow mesenchymal stem cells of myelodysplastic syndromes.
24-aug-2026
novelty 3
per-area 3
strengthens
Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss.
14-aug-2026
novelty 3
per-area 2
strengthens
Fibrillarin Resists Cellular Senescence Via SIRT1-Dependent Nicotinamide Metabolism and Its Inhibition Sensitizes Senolytic Therapy in Esophageal Squamous Cell Carcinoma.
10-aug-2026
novelty 3
per-area 3
strengthens
Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.
05-aug-2026
novelty 3
per-area 3
strengthens
Targeting Cellular Senescence in Kidney Aging with Traditional Chinese Medicine: Potential Senolytic and Senomorphic Strategies.
03-aug-2026
novelty 2
per-area 2
mentions
Crocin I delays cellular senescence potentially via modulating SIRT1/PKM2 expression to improve lactate homeostasis.
29-jul-2026
novelty 2
per-area 2
strengthens
Myokines as molecular mediators of the muscle-brain axis: Mechanisms linking sarcopenia to cognitive decline and implications for preventive strategies in ageing - A narrative review.
28-jul-2026
novelty 2
per-area 2
mentions
Sodium Danshensu alleviates oxidative stress-induced endothelial apoptosis and senescence by modulating the SIRT1/p53 pathway.
28-jul-2026
novelty 2
per-area 2
strengthens
Cellular Senescence in Diabetic Cardiomyopathy: Mechanistic Insights and Therapeutic Perspectives.
28-jul-2026
novelty 2
per-area 2
strengthens
Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.
27-jul-2026
novelty 2
per-area 2
mentions
SIRT3 inhibition promotes age-associated vascular impairment by mediating mitochondrial dysfunction and endothelial-to-mesenchymal transition.
25-jul-2026
novelty 3
per-area 3
strengthens
Galangin attenuates UVB-induced skin photoaging through SIRT1-dependent LC3 deacetylation and autophagy modulation.
23-jul-2026
novelty 3
per-area 3
strengthens
Exercise attenuates atherosclerosis by inhibiting eWAT aging via targeting SIRT1/pyruvate carboxylase pathway.
23-jul-2026
novelty 3
per-area 3
strengthens
The SIRT5-SUCLG2 desuccinylation axis delays ovarian aging via a mitochondrial-epigenetic regulatory mechanism.
15-jul-2026
novelty 3
per-area 3
strengthens
Sea buckthorn flavonoid IGRh and its metabolites delay Caenorhabditis elegans aging via SIR-2.1/DAF-16-mediated IIS and autophagy-lysosomal pathways.
14-jul-2026
novelty 2
per-area 2
strengthens
Aerobic conditioning and ginsenoside modulation modify molecular resilience in middle-aged rats: Differential effects of individual and combined interventions.
11-jul-2026
novelty 2
per-area 2
strengthens
Anthocyanins and Aging Intervention: Mechanisms and Prospects.
10-jul-2026
novelty 2
per-area 2
strengthens
Dietary bioactive compounds and inflammaging: Pro-inflammatory triggers and geroprotective countermeasures.
09-jul-2026
novelty 2
per-area 2
strengthens
Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ-Induced Alzheimer's Disease Model Mice.
07-jul-2026
novelty 2
per-area 2
strengthens
Sirtuins in Alzheimer's disease: Global research trends and bibliometric insights.
06-jul-2026
novelty 2
per-area 2
strengthens
Screening and Activity Profiling of Antisenescence Peptides from Silkworm Pupa Protein Hydrolysate: Discovery of a Bioactive Hexapeptide FKVPNM.
01-jul-2026
novelty 3
per-area 2
strengthens
Factors Determining Sirtuin-1 Target Engagement.
01-jul-2026
novelty 2
per-area 2
introduces
Meta-analysis of DNA methylation aging signatures in 17 human tissues.
26-jun-2026
novelty 3
per-area 3
strengthens
Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.
19-jun-2026
novelty 4
per-area 4
strengthens
Endurance exercise improves age- and obesity-related cardiac dysfunction and locomotor impairment through muscle Gγ1 gene in Drosophila.
05-jun-2026
novelty 3
per-area 3
strengthens
Ceramic-based biomaterials: Combining regeneration with anti-senescence.
02-apr-2026
novelty 4
per-area 4
strengthens
Caloric restriction attenuates age-related liver and kidney alterations in mice: Histological evidence.
24-mar-2026
novelty 2
per-area 2
strengthens
Restoring NAD⁺-Sirtuins Signaling: A Novel Approach to Combat Male Reproductive Aging.
06-feb-2026
novelty 2
per-area 3
strengthens